Developed by Xiamen University National Infectious Diagnosis Reagent and Vaccine Engineering Technology Research Center、Xiamen Wantai Canghai stake sports betting appBiotechnology Co., Ltd. realized the world's first pentalitis vaccine,officially listed on Xiamen on the 27th。

    Hepatitis is an acute epidemic viral hepatitis that is currently spreading around the world,Its symptoms are similar to hepatitis A,But the mortality rate is higher,Especially for pregnant women、Elderly people and patients with chronic liver disease are more harmful。Data display provided by the World Health Organization in July 2012,About 20 million people in the world are infected with hepatitis。But before the world did not have effective treatment methods for hepatitis infection。

    Yi Keen has been for 2 years before listing、Large -scale clinical trials with 113,000 people involved。Results Digesting,Vaccine played an ideal protective role。The successful development of Chinese scientists for pentalitis vaccines is known as a major breakthrough in the field of scientific and industrial circles in the international pharmaceutical industry as a major breakthrough stake betting appin the field of hepatitis in the world.。

    The China Hepatitis Prevention and Control Foundation is successfully listed on Yichinin,Hanging & ldquo in Xiamen on the 27th; the seminar and hazardous seminar of the liver epidemic disease and the world's first puppet vaccine promotion meeting & rdquo;。More than 200 people from the Ministry of Health、Department of Technology、China Disease Prevention and Control Center and experts from all over the country、Scholar,The current status of the popular hepatitis、Chinese pentitis epidemiology and control strategies delivered a special speech。

    Yi Keen opened a new way for the development of the world's innovative vaccine。Xiamen University National Infectious Diagnosis Reagent and Vaccine Engineering Technology Research Center uses E. coli as an expression system,original and yeast、insect cells、R & D path of fourth gene engineering vaccine in parallel mammal cells,After 14 years of exploration,Invest nearly 500 million yuan,Build an independent innovative My stake betting appplatform for Chinese biopharmaceuticals to break the international monopoly。

    Gao Yongzhong, general manager of Xiamen Wantai Canghai stake sports betting appBiotechnology Co., Ltd.,The company will apply the vaccine as soon as possible to women of childbearing age、Student、Prevention of high -risk groups such as elderly people,At the same time, actively cooperate with the World Health Organization and other international public welfare organizations,Strive for the vaccine to benefit the people in other countries and regions of other countries and regions in other countries and regions as soon as possible。